It is a pharma private limited company based in Chennai, Tamil Nadu, India, established in 1989.
1989 | Chennai, Tamil Nadu, India | ActiveSri Srinivasa Drugs Private Limited, a active private limited company, was established on 27 December 1989 in Chennai, Tamil Nadu, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U24231TN1989PTC018522. Registered under ROC Roc Chennai. it is unlisted. It has an authorized capital of ₹6.00 M and a paid-up capital of ₹4.08 M.
Formerly known as Sri Srinivasa Drugs Limited. It upholds a active non-compliant status. Its leadership includes Pandurengan Venkatesan (Director), Jagannathan Balaji (Director). Past directors included Jayanthi Balaji, Venkatesan Ragothuman. It holds no open charges and ₹8.06 M settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at No.447/19, Lalbahadur Sasthri Street Sholinganallur, Chennai, Tamil Nadu, 600119.
U24231TN1989PTC018522
018522
27 December 1989
₹6.00 M
₹4.08 M
Roc Chennai
Unlisted
Active
Explore comprehensive insights into Sri Srinivasa Drugs Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Pandurengan Venkatesan | Director | 07 Dec 2012 | Current |
| Jagannathan Balaji | Director | 07 Mar 2007 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Managing Director | 10 Dec 2012 | Past |
| Pramod Abcsdd | Director | 11 Dec 2018 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Sri Srinivasa Drugs Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 382.61% decrease in profit. The company's net worth dipped by a decrease of 4.93%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Sri Srinivasa Drugs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹8,061,500.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 10 Mar 1995 | The Tamil Nadu Industrial Investment Corpn. Ltd. | ₹0.06 M | Satisfied |
| 05 Aug 1994 | The South Indian Bank Limited | ₹5.00 M | Satisfied |
| 18 Feb 1994 | The Tamil Nadu Industrial Investment Corpn. Limited | ₹0.24 M | Satisfied |
| 16 Mar 1992 | The Tamil Nadu Industrial Investment Corpn. Limited | ₹2.76 M | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Sri Srinivasa Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Sri Srinivasa Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sri Srinivasa Drugs's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Sri Srinivasa Drugs Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Sri Srinivasa Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chennai. was recorded as a recent event.
The activity A charge registered on 05 Aug 1994 via Charge ID 90300410 with The South Indian Bank Limited was fully satisfied on 02 Feb 2022. was completed.
A charge registered on 10 Mar 1995 via Charge ID 90298550 with The Tamil Nadu Industrial Investment Corpn. Ltd. was fully satisfied on 10 Aug 2021. was recorded as a recent event.
A charge registered on 18 Feb 1994 via Charge ID 90298536 with The Tamil Nadu Industrial Investment Corpn. Limited was fully satisfied on 10 Aug 2021. was recorded as a recent event.
Progress on A charge registered on 16 Mar 1992 via Charge ID 90303267 with The Tamil Nadu Industrial Investment Corpn. Limited was fully satisfied on 10 Aug 2021. was documented.
The CIN of Sri Srinivasa Drugs Private Limited is U24231TN1989PTC018522.
Sri Srinivasa Drugs Private Limited is headquartered at No.447/19, Lalbahadur Sasthri Street Sholinganallur, Chennai, Tamil Nadu, 600119.
Sri Srinivasa Drugs Private Limited was incorporated on 27 December 1989.
The current directors of Sri Srinivasa Drugs Private Limited are
The primary industry of Sri Srinivasa Drugs Private Limited is Trade.
Sri Srinivasa Drugs Private Limited is unlisted.
The authorized capital of Sri Srinivasa Drugs Private Limited is ₹6.00 M, and the paid-up capital is ₹4.08 M.
The compliance status of Sri Srinivasa Drugs Private Limited is Active Non-Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX